The board of directors of dental supplier Patterson Companies approved a new share repurchase authorization.
Under the authorization, the company can repurchase up to $500 million of its common stock through March 16, 2027, according to a March 11 news release from Patterson.
The new approval replaces the previous repurchase authorization, which was expiring with $194.9 million remaining.
Patterson's board also announced a quarterly cash dividend of $0.26 per share, the release said.